tiprankstipranks
Kraig Biocraft Laboratories Inc (KBLB)
OTHER OTC:KBLB

Kraig Biocraft Laboratories Stock Analysis & Ratings

KBLB Stock Chart & Stats

Day’s Range$0.07 - $0.0739
52-Week Range$0.06 - $0.15
Previous Close$0.07
Volume1.14M
Average Volume (3M)995.76K
Market Cap$67.12M
P/E Ratio-7.6
Beta-0.14
Next EarningsMay 11, 2018
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3
EPS (TTM)-0.01


Kraig Biocraft Laboratories News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

KBLB FAQ

What was Kraig Biocraft Laboratories’s price range in the past 12 months?
Kraig Biocraft Laboratories lowest stock price was $0.06 and its highest was $0.15 in the past 12 months.
    What is Kraig Biocraft Laboratories’s market cap?
    Kraig Biocraft Laboratories’s market cap is $67.12M.
      What is Kraig Biocraft Laboratories’s price target?
      Currently, no data Available
      What do analysts say about Kraig Biocraft Laboratories?
      Not enough analysts have published a price target to provide an average price target.
      When is Kraig Biocraft Laboratories’s upcoming earnings report date?
      Kraig Biocraft Laboratories’s upcoming earnings report date is May 11, 2018 which is 1466 days ago.
        How were Kraig Biocraft Laboratories’s earnings last quarter?
        Currently, no data Available
        Is Kraig Biocraft Laboratories overvalued?
        According to Wall Street analysts Kraig Biocraft Laboratories’s price is currently Overvalued.
          Does Kraig Biocraft Laboratories pay dividends?
          Kraig Biocraft Laboratories does not currently pay dividends.
          What is Kraig Biocraft Laboratories’s EPS estimate?
          Kraig Biocraft Laboratories’s EPS estimate is $0.
            How many shares outstanding does Kraig Biocraft Laboratories have?
            Kraig Biocraft Laboratories has 957,540,000 shares outstanding.
              What happened to Kraig Biocraft Laboratories’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Kraig Biocraft Laboratories?
              Currently, no hedge funds are holding shares in KBLB

              ---

              Kraig Biocraft Laboratories Stock Analysis

              Smart Score
              3
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              Price Target
              No data currently available
              The Kraig Biocraft Laboratories stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Kraig Biocraft Laboratories Inc

              Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. It specializes in the global textiles industry, genetic research and product development. The company was founded by Kim K. Thompson on April 25, 2006 and is headquartered in Ann Arbor, MI.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Eastman Chemical
              Culp
              Unifi

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis